Ignet
Search (e.g., vaccine, IFNG): Help
About
Home
Introduction
Statistics
Programs
Dignet
Gene
GenePair
BioSummarAI
Help & Docs
Documents
Help
FAQs
Links
Acknowledge
Disclaimer
Contact Us
UM Logo

UMMS Logo

UMMS Logo

Gene Information

Gene symbol: SOSTDC1

Gene name: sclerostin domain containing 1

HGNC ID: 21748

Synonyms: DKFZp564D206, USAG1

Related Genes

# Gene Symbol Number of hits
1 CTGF 1 hits
2 RCA1 1 hits
3 SMAD1 1 hits
4 SYNPO 1 hits

Related Sentences

# PMID Sentence
1 18032587 Because SOSTDC1 suppresses proliferation of renal carcinoma cells, restoration of SOSTDC1 signaling may represent a novel target in treatment of renal clear cell carcinoma.
2 19255250 Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
3 19255250 BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
4 19255250 Nephrin and synaptopodin were decreased in diabetic glomeruli.
5 19255250 SOSTDC1 and CTGF were expressed exclusively in podocytes.
6 19255250 In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
7 19255250 This might relate to concomitant overexpression of CTGF but not SOSTDC1.
8 19255250 Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
9 19255250 BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
10 19255250 Nephrin and synaptopodin were decreased in diabetic glomeruli.
11 19255250 SOSTDC1 and CTGF were expressed exclusively in podocytes.
12 19255250 In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
13 19255250 This might relate to concomitant overexpression of CTGF but not SOSTDC1.
14 19255250 Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
15 19255250 BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
16 19255250 Nephrin and synaptopodin were decreased in diabetic glomeruli.
17 19255250 SOSTDC1 and CTGF were expressed exclusively in podocytes.
18 19255250 In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
19 19255250 This might relate to concomitant overexpression of CTGF but not SOSTDC1.
20 19255250 Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
21 19255250 BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
22 19255250 Nephrin and synaptopodin were decreased in diabetic glomeruli.
23 19255250 SOSTDC1 and CTGF were expressed exclusively in podocytes.
24 19255250 In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
25 19255250 This might relate to concomitant overexpression of CTGF but not SOSTDC1.
26 19255250 Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
27 19255250 BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
28 19255250 Nephrin and synaptopodin were decreased in diabetic glomeruli.
29 19255250 SOSTDC1 and CTGF were expressed exclusively in podocytes.
30 19255250 In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
31 19255250 This might relate to concomitant overexpression of CTGF but not SOSTDC1.